Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Hollywood Wants To Use AI Replicas Of Actors, Major US Banks Deliver Q2 Earnings, Artificial Sweetener Aspartame Classified As 'Possible Carcinogen:' Today's Top Stories
Tickers ATVI BLK C ERIC
Tags Markets NOK MSFT
From Benzinga
Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease(s) Drug Deal
Tickers PFE RHHBF RHHBY RHHVF
Tags Market News Benzinga PFE
From Benzinga
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
Tickers HALO RHHBF RHHBY RHHVF
Tags News Briefs Biotech
From Benzinga
Monkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine Candidate
Tickers BWV RHHBY
Tags News Briefs General
From Benzinga
Roche's Bispecific Antibody With Fixed-Duration Treatment Scores FDA Approval For Type Of Lymphoma
Tickers RHHBF RHHBY RHHVF
Tags General RHHBY Health Care
From Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
Tickers EYPT REGN RHHBY
Tags Biotech Health Care REGN
From Benzinga
New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control
Tickers AZN RHHBF RHHBY RHHVF
Tags News Briefs AZN
From Benzinga
AI: An Endless Opportunity or Existential Threat?
Tickers AAPL GOOGL ICAD IRBT
Tags MSFT GOOGL NVDA
From InvestorPlace
Why Shares of Zentalis Pharmaceuticals Dropped This Week
Tickers RHHBY ZNTL
Tags Recent Press Releases ZNTL RHHBY
From Motley Fool
Why Shares of Rain Oncology Are Plummeting Today
Tickers RAIN RHHBY
Tags RAIN Market News Recent Press Releases
From Motley Fool
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Tickers ABBV AZN BCS CS
Tags ON RHHBY SPY
From Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Tickers MKGAF RHHBF RHHBY RHHVF
Tags RHHBY General News
From Benzinga
AI Meets Biotech: Transforming the Drug Development Process
Tickers AZN BAYRY RHHBY SNY
Tags Market News BAYRY RHHBY
From InvestorPlace
3 Stocks That Are Reshaping the Future
Tickers MSFT RHHBY ZBH
Tags Market News ZBH Stocks to Buy
From InvestorPlace
3 Personalized Medicine Stocks to Buy for Long-Time Returns
Tickers ADPT EXAS GSK ME
Tags Market News ME Stocks to Buy
From InvestorPlace
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
Tickers RHHBY SABS
Tags Exclusives Top Stories Market/Moving Exclusives
From Benzinga
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
Tickers RHHBY TPST
Tags Health Care Biotech Benzinga
From Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
Tickers RHHBF RHHBY RHHVF
Tags Market News RHHVF RHHBF
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
Tickers REGN RHHBY SABS
Tags Market News Exclusives Penny Stocks
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
Tickers BGNE BIIB LLY NVS
Tags NVS RHHBY Recent Press Releases
From Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
Tickers ABT DXCM RHHBY TECH
Tags Tech Market News Benzinga
From Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
Tickers RHHBF RHHBY RHHVF
Tags Large Cap Biotech Health Care
From Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
Tickers RHHBF RHHBY RHHVF SABS
Tags News RHHBY General
From Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
Tickers ADAP GSK RHHBY
Tags ADAP RHHBY Recent Press Releases
From Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
Tickers BMY BOLT RHHBY
Tags BMY Health Care Biotech
From Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
Tickers RHHBY
Tags Recent Press Releases RHHBY Market News
From Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
Tickers LLY RHHBY
Tags News Briefs Eurasia
From Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
Tickers RHHBF RHHBY RHHVF
Tags Eurasia Biotech Large Cap
From Benzinga
Is Roche a Buy Now?
Tickers RHHBY
Tags Market News Recent Press Releases RHHBY
From Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
Tickers RHHBY SRPT
Tags Movers why it's moving Briefs
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.